Dongfeng Qi | Engineering | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Prof. Dongfeng Qi | Engineering | Best Researcher Award

Professor | Shandong University of Technology | China

Prof. Dongfeng Qi is a leading researcher in laser manufacturing and material processing, specializing in femtosecond and nanosecond laser applications for advanced materials and flexible electronics. His work integrates theoretical modeling with experimental techniques to develop innovative micro- and nanostructures, including copper and silicon-based materials, phase-change films, and smart electronic devices. Prof. Qi has made substantial contributions to understanding laser-material interactions and patterning technologies, with high-impact publications in top-tier journals. He demonstrates strong interdisciplinary collaboration and mentorship, fostering international research partnerships and the growth of emerging scientists. His research is recognized for both fundamental insights and practical applications in photonics, energy storage, and flexible electronics. Prof. Qi’s consistent innovation, high-quality experimental work, and leadership in the field establish him as a leading figure in laser-based materials science. According to Scopus, he has 535 citations, 71 documents, and an h-index of 13.

Profiles: Scopus | Google Scholar

Featured Publications

1. Programming nanoparticles in multiscale: optically modulated assembly and phase switching of silicon nanoparticle array; L. Wang, Y. Rho, W. Shou, S. Hong, K. Kato, M. Eliceiri, M. Shi, …; ACS Nano, vol. 12, no. 3, pp. 2231–2241, 2018; 39 citations

2. Time-resolved analysis of thickness-dependent dewetting and ablation of silver films upon nanosecond laser irradiation; D. Qi, D. Paeng, J. Yeo, E. Kim, L. Wang, S. Chen, C. P. Grigoropoulos; Applied Physics Letters, vol. 108, no. 21, 2016; 37 citations

3. Femtosecond laser-induced large area of periodic structures on chalcogenide glass via twice laser direct-writing scanning process; X. Yu, Q. Zhang, D. Qi, S. Tang, S. Dai, P. Zhang, Y. Xu, X. Shen; Optics & Laser Technology, vol. 124, 105977, 2020; 34 citations

4. Progress in the design, nanofabrication, and performance of metalenses; Z. Wang, Y. Wu, D. Qi, W. Yu, H. Zheng; Journal of Optics, vol. 24, no. 3, 033001, 2022; 31 citations

5. Progress in preparation and applications of Te-As-Se chalcogenide glasses and fibers; Z. Wu, Y. Xu, D. Qi, Q. Nie, X. Zhang; Infrared Physics & Technology, vol. 102, 102981, 2019; 31 citations

Geng-Long Hsu | Medicine and Dentistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Prof. Dr. Geng-Long Hsu | Medicine and Dentistry | Best Researcher Award

Director | Hsu’s Andrology | Taiwan

Prof. Dr. Geng-Long Hsu is a distinguished urologist and microsurgical potency reconstruction specialist with decades of experience in clinical practice, research, and education. He has pioneered innovative surgical techniques and contributed significant anatomical and physiological insights in male reproductive medicine. His leadership in multiple research centers and academic institutions has fostered a strong culture of mentorship and collaboration. Dr. Hsu is recognized internationally through memberships in professional societies and numerous awards for both basic and clinical research, highlighting the global impact of his work. His research demonstrates a consistent focus on advancing urological science, integrating clinical expertise with experimental innovation. Through his contributions, he has influenced treatment protocols and surgical outcomes in male reproductive health. His measurable research impact is reflected in Scopus, with 1,521 citations across 68 documents and an h-index of 22, underscoring the significance and reach of his scholarly work.

Profiles: Scopus | ORCID

Featured Publications

1. G.-L. Hsu, “Combining erection restoration and factual penile enhancement based on revolutionary penile fibro-vascular assembly,” Archivos Espanoles De Urologia, 2025.

2. G.-L. Hsu, “A detailed analysis of the penile fibro-vascular assembly,” Journal of Sexual Medicine, 2025.

3. G.-L. Hsu, “Coil embolization is not justified for treating patients with veno-occlusive dysfunction: Case series and narrative literature review,” Life, 2024.

4. G.-L. Hsu, “Emergent penile venous stripping for treating adolescent impotence,” Life, 2024.

5. G.-L. Hsu, “A case report of right cardiac ventricle perforation by uncontrolled embolization coil inserted for treating penile veno-occlusive dysfunction,” Urology Case Reports, 2022.

Panagiota Koutsimani | Neuropsychology | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Panagiota Koutsimani | Neuropsychology | Best Researcher Award

Adjunt Lecturer | University of Western Macedonia | Greece

Dr. Panagiota Koutsimani is a cognitive neuropsychologist specializing in burnout, cognitive functioning, and mental health. She holds a PhD in Cognitive Psychology from the University of Macedonia and is currently a postdoctoral researcher at Aristotle University of Thessaloniki. Her research has significantly contributed to understanding the relationships between burnout, depression, and anxiety, notably through her widely cited meta-analysis published in Frontiers in Psychology. She has also investigated cognitive performance in non-clinical burnout populations, highlighting the role of family support as a protective factor. Her work employs rigorous methodologies, including longitudinal studies and meta-analyses, reflecting a strong commitment to advancing psychological research. In addition to her research, Dr. Koutsimani has extensive teaching and dissertation supervision experience, mentoring emerging researchers in both cognitive and neuropsychology fields. According to her Google Scholar profile, total citations 1903, since 2020 citations 1854, h-index 8, i10-index 7.

Profile: Scopus | Google Scholar

Featured Publications

1. P. Koutsimani, A. Montgomery, and K. Georganta, “The relationship between burnout, depression, and anxiety: A systematic review and meta-analysis,” Frontiers in Psychology, vol. 10, p. 429219, 2019.

2. A. Kariou, P. Koutsimani, A. Montgomery, and O. Lainidi, “Emotional labor and burnout among teachers: A systematic review,” International Journal of Environmental Research and Public Health, vol. 18, no. 23, p. 12760, 2021.

3. P. Koutsimani, A. Montgomery, E. Masoura, and E. Panagopoulou, “Burnout and cognitive performance,” International Journal of Environmental Research and Public Health, vol. 18, no. 4, p. 2145, 2021.

4. P. Koutsimani, A. Montgomery, and K. Georganta, “The relationship between burnout, depression, and anxiety: A systematic review and meta-analysis,” Frontiers in Psychology, vol. 10, p. 284, 2019.

5. P. Koutsimani and A. Montgomery, “A two-wave study on the associations of burnout with depression and anxiety: The mediating and moderating role of perceived family support,” Psychological Reports, vol. 126, no. 1, pp. 220–245, 2023.

Amir Maharjan | Wildlife Conservation | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Mr. Amir Maharjan | Wildlife Conservation | Best Researcher Award

Amir Maharjan | University of Southern Queensland | Australia

Mr. Amir Maharjan is an accomplished researcher in wildlife conservation and forestry, with extensive experience in national parks and biodiversity management. His research focuses on tiger ecology, prey dynamics, human-wildlife conflict, and adaptive conservation strategies, reflecting a strong blend of applied and theoretical expertise. He has actively contributed to international conferences and policy platforms, including the Convention on Biological Diversity and IPBES, demonstrating recognition of his work at both national and global levels. In addition to field research, he has supervised undergraduate theses and mentored students, emphasizing capacity-building in forestry and wildlife science. His work integrates ecological monitoring, habitat suitability mapping, and conservation policy, bridging research and practical applications. According to Scopus, his research output includes 3 documents with 11 citations and an h-index of 3, showcasing measurable research impact. Citations by 11 documents.

Profile: Scopus

Featured Publications

1. A. Maharjan, “Assessing the Spatio-temporal Activity Pattern and Habitat Use of Bengal Tiger (Panthera tigris tigris) Across Three Forest Management Regimes in Nepal,” Biodiversity and Conservation, 2025.

 

Bushra Naz | Deep learning | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Bushra Naz | Deep learning | Best Researcher Award

Associate professor at Mehran University of Engineering and Technology| Pakistan

Dr. Bushra Naz is an accomplished academic and researcher with expertise in artificial intelligence, deep learning, image processing, hyperspectral image classification, and pattern recognition. Serving as an Associate Professor and PhD supervisor, she has made significant contributions to advancing knowledge through impactful research and dedicated mentorship. Her funded projects include innovative solutions in speech emotion recognition, assistive technologies for visually impaired individuals, water quality monitoring, and sustainable agriculture, reflecting a strong focus on societal benefit. She has published widely, reviewed for leading international journals, and actively participated in global conferences as a session chair and committee member. Her achievements are further recognized through prestigious scholarships, research fellowships, and honors that demonstrate her academic excellence and leadership. With a commitment to bridging theory and practice, Dr. Naz continues to drive interdisciplinary collaborations and inspire future researchers, positioning herself as a leader in advancing AI-driven solutions for real-world challenges.

Professional Profile 

Google Scholar

Education

Dr. Bushra Naz has a strong academic foundation in computer systems and engineering, beginning with a bachelor’s degree in Computer Systems Engineering, followed by a master’s degree in Communication Systems and Networks. She pursued her doctoral studies at Nanjing University of Science and Technology, China, where she completed a PhD in Computer Science and Engineering with a research focus on machine learning and hyperspectral image classification. Her doctoral thesis explored advanced elastic-net representation methods for image classification, demonstrating her early commitment to innovative AI-driven solutions. She also earned international recognition during her doctoral journey, supported by prestigious scholarships and fellowships, which allowed her to gain global exposure and strengthen her research expertise. With a solid academic trajectory rooted in both national and international institutions, Dr. Naz has combined technical depth with interdisciplinary knowledge, equipping her with the skills to pursue cutting-edge research while training the next generation of scholars and professionals.

Experience

Dr. Bushra Naz brings extensive academic and research experience spanning over a decade. She began her professional journey as a laboratory lecturer, progressively advancing to lecturer, assistant professor, and currently serves as an associate professor in the Department of Computer Systems Engineering at Mehran University of Engineering and Technology, Jamshoro. In these roles, she has taught a diverse range of subjects including microprocessors, operating systems, digital image processing, machine learning, deep learning, and artificial intelligence, shaping the technical skills of numerous students. Beyond teaching, she has taken on leadership roles in departmental committees, project supervision, curriculum review, and outcome-based education implementation. Her responsibilities also include supervising undergraduate, master’s, and doctoral research projects, many of which align with pressing technological and societal challenges. Through her experience, she has built a reputation as a dedicated educator, innovative researcher, and academic leader who seamlessly integrates research and teaching to drive meaningful outcomes.

Research Focus

Dr. Bushra Naz’s research focus lies in the application of artificial intelligence and machine learning to solve complex real-world problems. Her expertise covers deep learning, neural networks, hyperspectral imaging, image classification, object detection, and pattern recognition. She has conducted pioneering research in spectral-spatial methods for image classification, advancing techniques in optimization and sparse representation. Her projects span diverse domains, including speech emotion recognition, augmented reality-based navigation for the visually impaired, IoT-driven water quality monitoring, crop sensing for sustainable agriculture, and accident detection systems. This interdisciplinary approach highlights her commitment to applying AI solutions for societal impact, sustainability, and technological innovation. In addition, she actively contributes as a reviewer for high-impact journals and participates in international conferences as a session chair, strengthening global research dialogue. By integrating technical rigor with practical application, Dr. Naz continues to expand the frontiers of AI research while addressing challenges that directly benefit communities and industries.

Award and Honor

Dr. Bushra Naz’s academic excellence and research contributions have been recognized through numerous awards and honors at national and international levels. She received the prestigious China Scholarship Council award for her PhD studies and was further distinguished with the ELITE Scholarship as the Best Foreign Student during her doctoral program. Her excellence in research was acknowledged with honor certificates and rewards for her publications in IEEE journals. Earlier in her career, she earned the Higher Education Commission of Pakistan’s fully funded scholarship for her master’s studies and received merit-based scholarships during her undergraduate years. She also secured the UNESCO/People’s Republic of China Co-Sponsored Fellowship as a senior research scholar, reflecting her growing international recognition. These accolades not only highlight her academic dedication but also underscore her ability to compete successfully at global platforms. Collectively, her awards showcase her talent, perseverance, and impactful contributions to engineering and computer science research.

Publication Top Notes

  • Title: Sustainable Higher Education Reform Quality Assessment Using SWOT Analysis with Integration of AHP and Entropy Models: A Case Study of Morocco
    Year: 2021
    Citations: 64

  • Title: Spatial-Hessian-feature-guided variational model for pan-sharpening
    Year: 2015
    Citations: 50

  • Title: Fast superpixel based subspace low rank learning method for hyperspectral denoising
    Year: 2018
    Citations: 44

  • Title: Bilayer elastic net regression model for supervised spectral-spatial hyperspectral image classification
    Year: 2016
    Citations: 28

  • Title: Hybrid LSTM Self-Attention Mechanism Model for Forecasting the Reform of Scientific Research in Morocco
    Year: 2021
    Citations: 25

  • Title: Onion Crop Monitoring with Multispectral Imagery using Deep Neural Network
    Year: 2021
    Citations: 14

  • Title: A machine learning framework for major depressive disorder (MDD) detection using non-invasive EEG signals
    Year: 2025
    Citations: 13

  • Title: Sustainable higher education reform quality assessment using SWOT Analysis with integration of AHP and Entropy models: A case study of Morocco
    Year: 2021
    Citations: 13

  • Title: Local and nonlocal context-aware elastic net representation-based classification for hyperspectral images
    Year: 2017
    Citations: 8

  • Title: Hyperspectral image classification via Elastic Net Regression and bilateral filtering
    Year: 2015
    Citations: 8

Conclusion

Dr. Bushra Naz has established herself as a distinguished researcher and academic leader with a significant impact in the fields of artificial intelligence, machine learning, and hyperspectral image analysis. Her extensive research portfolio demonstrates a balance of theoretical innovation and practical application, addressing societal challenges such as sustainable agriculture, water quality monitoring, assistive technologies, and mental health detection. With a strong record of high-impact publications, international collaborations, research supervision, and active participation in conferences and editorial roles, she has consistently contributed to advancing knowledge and mentoring future researchers. Her achievements are further reinforced by prestigious awards, fellowships, and funded projects that recognize her scholarly excellence and leadership. Overall, Dr. Naz exemplifies the qualities of a visionary researcher—innovative, dedicated, and socially responsible—making her a highly deserving candidate for recognition through the Best Researcher Award.

Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Doctor at Medical University, Varna, Bulgaria

Dr. Yoana Dyankova Dyankova is a dedicated pediatrician and clinical researcher specializing in pediatric gastroenterology, hepatology, and nutrition. She holds a PhD in Pediatrics from the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, where she also serves in the Pediatric Intensive Care Unit at St. Marina University Hospital. Her research focuses primarily on celiac disease in children, particularly its impact on bone health, as demonstrated in her dissertation and multiple peer-reviewed publications, including a recent article in Nutrients (2025). Dr. Dyankova is an active member of national pediatric and gastroenterology associations and contributes to both clinical care and academic development. Fluent in English and German, she engages with the international scientific community and remains committed to translating research into improved patient outcomes. With her growing publication record, clinical integration, and academic rigor, she stands out as a promising young researcher in the field of pediatric medicine.

Professional Profile 

Google Scholar
ORCID Profile 

Education

Dr. Yoana Dyankova Dyankova began her academic journey at the Vasil Drumev High School of Natural Sciences and Mathematics in Veliko Tarnovo, graduating in 2010. She pursued her medical degree at the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, completing it in 2016. From 2017 to 2022, she specialized in pediatrics, gaining comprehensive clinical training and board certification in the field. In 2018, she enrolled in a PhD program in Pediatrics at the same university, where she focused her research on celiac disease and its effects on pediatric bone health. She successfully defended her dissertation in 2023. Dr. Dyankova has since continued to develop professionally by pursuing further specialization in pediatric gastroenterology starting in July 2025. Her academic path demonstrates strong commitment, discipline, and a focused interest in improving pediatric healthcare through both clinical practice and rigorous scientific research.

Professional Experience

Dr. Dyankova has cultivated a balanced career combining clinical excellence and academic growth. Since January 2022, she has served as a pediatrician at the Pediatric Intensive Care Unit (PICU) of the First Children’s Clinic, St. Marina University Hospital in Varna. Her role in the PICU places her at the frontline of managing critically ill children, often requiring advanced decision-making and teamwork in high-pressure situations. Prior to this, she completed a five-year pediatric residency, gaining hands-on experience in general pediatrics. Her transition into the subspecialty of pediatric gastroenterology as of July 2025 marks a strategic shift aligned with her research interests. Parallel to her clinical duties, Dr. Dyankova was engaged in doctoral studies for five years, conducting original research and contributing to academic publications. Her dual role as both a clinician and researcher enhances her ability to apply scientific findings directly to patient care, making her a valuable asset in modern pediatric medicine.

Research Interest

Dr. Dyankova’s primary research interests lie at the intersection of pediatric gastroenterology, hepatology, and nutrition, with a concentrated focus on celiac disease (CD). Her doctoral thesis explored bone health in children with CD, addressing the metabolic and developmental complications arising from malabsorption and chronic inflammation. Beyond celiac disease, she has expressed research interest in related gastrointestinal disorders such as inflammatory bowel disease (IBD), as well as broader issues within pediatric intensive care. Her work is characterized by clinical relevance and translational value, aiming to bridge the gap between scientific research and bedside care. Publications in both national and international journals reflect her dedication to improving diagnostic and treatment protocols in children with chronic gastrointestinal conditions. Dr. Dyankova continues to build her research portfolio by participating in collaborative studies, focusing on early diagnosis, nutritional interventions, and long-term management outcomes in affected pediatric populations, ensuring a direct impact on clinical practice.

Award and Honor

While specific named awards are not listed in the biography, Dr. Yoana Dyankova Dyankova has received notable academic and professional recognition through her successful completion of a PhD and multiple scientific publications. Her research has been published in reputable journals such as Nutrients, indicating peer validation and relevance of her work. She is an active member of the National Pediatric Association and the community of Pediatric Gastroenterologists in Bulgaria, reflecting her standing in the professional community. These memberships signify not only recognition by peers but also her continued contribution to scientific discussions and advancements in pediatric healthcare. Her role in high-stakes clinical environments like the Pediatric Intensive Care Unit further demonstrates trust in her medical competence and decision-making. With growing academic output and clear specialization in a crucial field, Dr. Dyankova is well-positioned to earn future distinctions and leadership roles in pediatric research and clinical practice at both national and international levels.

Conclusion

Dr. Yoana Dyankova Dyankova exemplifies the qualities of a dedicated clinician-scientist, balancing hands-on pediatric care with high-impact academic research. With a solid foundation in pediatrics and a focused interest in gastroenterology and nutrition, she has steadily advanced her career through both clinical excellence and scholarly contribution. Her doctoral work on bone health in children with celiac disease highlights her ability to address complex, real-world health challenges through evidence-based research. Now working in a pediatric intensive care setting and continuing her subspecialty training, Dr. Dyankova is expanding her expertise and influence in critical areas of child health. Her publications, professional affiliations, and academic achievements underscore a deep commitment to the advancement of pediatric medicine. While still early in her career, her trajectory suggests strong potential for leadership in research and healthcare. She is a promising candidate for recognition such as the Best Researcher Award and is well-poised for continued professional impact.

Publications Top Notes

  1. Title: Presentation of Childhood Newly-Diagnosed Diabetes During the COVID-19 Pandemic – Is There a Change?

    • Authors: Y. Bazdarska, V. Iotova, T. Karamfilova, Y. Dyankova, T. Stefanova, …

    • Journal: Diabetes Technology & Therapeutics, Vol. 23, A202

    • Year: 2021

  1. Title: Delayed Bone Age and Osteoprotegerin Levels in Pediatric Celiac Disease: A Three-Year Case–Control Study

    • Authors: R. Pancheva, Y. Dyankova, N. Rasheva, K. Koleva, V. Iotova, M. Dzhogova, M. Fiore, M. Georgieva

    • Journal: Nutrients, Vol. 17 (14), Article 2295

    • Year: 2025

  1. Title: Macrophage Activation Syndrome After COVID-19 Infection in a Patient with Systemic Juvenile Idiopathic Arthritis

    • Authors: M. Boyadzhiev, B. Varbanova, M. Belcheva, P. Shivachev, D. Krumova, Y. Dyankova, …

    • Journal: Scripta Scientifica Medica, Vol. 55(1), pp. 27–31

    • Year: 2023

  1. Title: Bone Health in Children with Celiac Disease (PhD Dissertation)

    • Author: Y. Dyankova

    • Database: PQDT-Global (ProQuest Dissertations)

    • Year: 2022

  1. Title: New Developments in the Diagnostics of Celiac Disease in Children

    • Authors: Y. Dyankova, M. Georgieva, N. Rasheva, K. Koleva

    • Journal: Journal of the Union of Scientists-Varna. Medicine and Ecology Series, Vol. 24(1)

    • Year: 2019

  1. Title: Bacterial Pulmonary Colonization with Pseudomonas aeruginosa in Cystic Fibrosis Patients

    • Authors: M. Nikolova, Y. Dyankova, I. Hristov, M. Georgieva

    • Journal: Izvestia Journal of the Union of Scientists-Varna. Medicine and Ecology Series

    • Year: 2019

Dr. Mohamed Selim | Chemistry | Best Researcher Award 

Published on | Editorial Board by World Top Scientists

Dr. Mohamed Selim | Chemistry | Best Researcher Award 

Assoc. Prof. Egyptian Petroleum Research Institute, Nasr city, Cairo, Egypt

Dr. Mohamed Sayed Selim is an accomplished Associate Professor at the Egyptian Petroleum Research Institute with over 15 years of research experience in applied chemistry, nanotechnology, and polymer science. He holds a Ph.D. in Organic Chemistry and has conducted extensive postdoctoral research in China and Japan, contributing significantly to advanced coating technologies, environmentally friendly nano-materials, and superhydrophobic surfaces. With a Scopus h-index of 32, over 3,000 citations, and 78 published papers, Dr. Selim has a well-established international research profile. He serves on editorial boards of multiple scientific journals and actively reviews for over 20 high-impact Elsevier publications. His expertise spans the synthesis of functional polymers and nanocomposites for industrial, environmental, and marine applications. A member of several scientific societies, he has demonstrated a strong commitment to academic excellence and collaborative research. Dr. Selim’s contributions position him as a leading figure in materials science and a strong contender for the Best Researcher Award.

Professional Profile 

Google Scholar
Scopus Profile

Education

Dr. Mohamed Sayed Selim holds a robust academic background in chemistry, beginning with a B.Sc. in Special Chemistry (2006) from Menoufiya University, where he graduated with excellence. He went on to earn his M.Sc. in Organic Chemistry in 2012, focusing on the synthesis of functional polymers for cement admixtures. He completed his Ph.D. in Organic Chemistry in 2015 from Ain Shams University, where his doctoral research concentrated on synthesizing environmentally friendly nano-marine antifouling paints. His academic training laid a strong foundation in polymer chemistry, nanomaterials, and surface science, which later became focal points in his professional research. Dr. Selim’s multidisciplinary education, blending organic synthesis with applied materials science, reflects a clear trajectory toward innovation in environmentally conscious technologies. His degrees were pursued in Egypt’s leading universities, positioning him for impactful contributions in both academic and industrial research sectors.

Professional Experience

Dr. Selim’s professional journey spans over 15 years, marked by progressive roles in academia and research. He is currently an Associate Professor at the Egyptian Petroleum Research Institute (EPRI), where he has held several positions since 2012, including Researcher and Assistant Researcher. His international research experience includes postdoctoral fellowships in China at the Guangdong University of Technology and the Chinese Academy of Sciences, and a recent Visiting Researcher role in 2024 at the National Institute for Materials Science (NIMS) in Japan. He also has industrial experience as a chemist in a powder coating factory, enriching his practical understanding of materials science. Dr. Selim’s roles have consistently involved the development of polymer-based materials, nanocoatings, and environmental applications. His professional trajectory highlights a unique blend of theoretical insight and practical execution, contributing to high-impact publications and international collaboration, all while advancing research at the intersection of chemistry, nanotechnology, and surface engineering.

Research Interest

Dr. Mhamed Selim’s research focuses on the synthesis and characterization of advanced polymers, nanomaterials, and environmentally friendly coatings. His work is particularly notable in superhydrophobic surfaces, marine antifouling coatings, and corrosion-resistant materials. He is deeply involved in designing hyper-branched polymers and functional nanocomposites with applications in biotechnology, environmental sustainability, and energy storage. Dr. Selim explores green synthetic approaches for nano-coatings and polymer composites, aligning his work with global priorities in eco-friendly technologies and industrial innovation. His research spans interdisciplinary fields, including applied chemistryhttps://worldtopscientists.com/dr-mohamed-selim-chemistry-best-researcher-award-3739/, materials engineering, and surface science. He has authored over 78 peer-reviewed papers and actively contributes as a reviewer for top-tier journals like Applied Surface Science, Journal of Energy Storage, and Ceramics International. Dr. Selim’s interests reflect a dedication to solving real-world challenges through scientific innovation, positioning him at the forefront of polymer and nanomaterials research in both academic and applied contexts.

Award and Honor

While the CV does not list formal awards, Dr. Selim’s recognition is evident through prestigious academic appointments and international collaborations. He was selected as a Visiting Researcher at Japan’s National Institute for Materials Science (NIMS), a globally respected research center, in 2024—an honor that reflects his expertise and reputation. Additionally, his role as a postdoctoral scholar at top-tier Chinese institutions such as the Chinese Academy of Sciences and Guangdong University of Technology further underscores international acknowledgment of his scientific contributions. He holds editorial board positions for several journals, including Current Chinese Science and Nanoarchitectonics, and serves as a peer reviewer for over 20 high-impact Elsevier journals. These editorial and reviewer roles signify trust and recognition by the global scientific community. Though formal awards are not detailed, Dr. Selim’s cumulative achievements, appointments, and service highlight a career marked by academic distinction, international collaboration, and professional respect.

Conclusion

Dr. Mohamed Sayed Selim stands out as a highly accomplished researcher in applied chemistry, with specialized expertise in polymers, nanomaterials, and eco-friendly coatings. His academic foundation, extensive international experience, and research productivity make him a valuable contributor to the global scientific community. With over 3,000 citations, a Scopus h-index of 32, and 78 publications, he demonstrates a sustained impact in his field. His research has direct applications in critical sectors such as environmental protection, energy, and marine engineering. Beyond publishing, he contributes significantly as a peer reviewer and editorial board member, reflecting his leadership and authority in the field. While additional recognition through formal awards would further validate his contributions, his qualifications and career trajectory position him as a strong candidate for the Best Researcher Award. Dr. Selim’s commitment to scientific advancement, interdisciplinary research, and international collaboration firmly establishes him as a leading figure in modern materials science.

Publications Top Notes

  • Title: Recent progress in marine foul-release polymeric nanocomposite coatings
    Authors: MS Selim, MA Shenashen, SA El-Safty, SA Higazy, MM Selim, H Isago, …
    Year: 2017
    Citations: 529

  • Title: Progress in biomimetic leverages for marine antifouling using nanocomposite coatings
    Authors: MS Selim, SA El-Safty, MA Shenashen, SA Higazy, A Elmarakbi
    Year: 2020
    Citations: 241

  • Title: Silicone/graphene oxide sheet-alumina nanorod ternary composite for superhydrophobic antifouling coating
    Authors: MS Selim, SA El-Safty, NA Fatthallah, MA Shenashen
    Year: 2018
    Citations: 171

  • Title: Silicone/ZnO nanorod composite coating as a marine antifouling surface
    Authors: MS Selim, H Yang, FQ Wang, NA Fatthallah, Y Huang, S Kuga
    Year: 2019
    Citations: 128

  • Title: Synthesis of ultrahydrophobic and thermally stable inorganic–organic nanocomposites for self-cleaning foul release coatings
    Authors: MS Selim, MA Shenashen, A Elmarakbi, NA Fatthallah, S Hasegawa, …
    Year: 2017
    Citations: 123

  • Title: Superhydrophobic coating of silicone/β–MnO₂ nanorod composite for marine antifouling
    Authors: MS Selim, H Yang, SA El-Safty, NA Fatthallah, MA Shenashen, FQ Wang, …
    Year: 2019
    Citations: 119

  • Title: Smart photo-induced silicone/TiO₂ nanocomposites with dominant [110] exposed surfaces for self-cleaning foul-release coatings of ship hulls
    Authors: MS Selim, SA El-Safty, MA El-Sockary, AI Hashem, OMA Elenien, …
    Year: 2016
    Citations: 113

  • Title: Eco-friendly design of superhydrophobic nano-magnetite/silicone composites for marine foul-release paints
    Authors: MS Selim, A Elmarakbi, AM Azzam, MA Shenashen, AM El-Saeed, …
    Year: 2018
    Citations: 108

  • Title: Ti₃C₂Tₓ@ Polyvinyl alcohol foam-Supported Phase Change Materials with Simultaneous Enhanced Thermal Conductivity and Solar-Thermal Conversion Performance
    Authors: Z Mo, P Mo, M Yi, Z Hu, G Tan, MS Selim, Y Chen, X Chen, Z Hao, X Wei
    Year: 2021
    Citations: 104

  • Title: Facile design of graphene oxide-ZnO nanorod-based ternary nanocomposite as a superhydrophobic and corrosion-barrier coating
    Authors: MS Selim, SA El-Safty, MA Abbas, MA Shenashen
    Year: 2021
    Citations: 102

  • Title: Sunflower oil-based hyperbranched alkyd/spherical ZnO nanocomposite modeling for mechanical and anticorrosive applications
    Authors: MS Selim, MA Shenashen, A Elmarakbi, AM El-Saeed, MM Selim, …
    Year: 2017
    Citations: 85

  • Title: Robust alkyd/exfoliated graphene oxide nanocomposite as a surface coating
    Authors: MS Selim, SA El-Safty, MA Shenashen, MA El-Sockary, OMA Elenien, …
    Year: 2019
    Citations: 72

  • Title: A comparative study between two novel silicone/graphene-based nanostructured surfaces for maritime antifouling
    Authors: MS Selim, NA Fatthallah, SA Higazy, Z Hao, PJ Mo
    Year: 2022
    Citations: 71

  • Title: Modeling of spherical silver nanoparticles in silicone-based nanocomposites for marine antifouling
    Authors: MS Selim, SA El-Safty, MA El-Sockary, AI Hashem, OMA Elenien, …
    Year: 2015
    Citations: 71

  • Title: Superhydrophobic Silicone/TiO₂–SiO₂ Nanorod‐like Composites for Marine Fouling Release Coatings
    Authors: OMAE Mohamed S. Selim, Sherif A. El-Safty, Ahmed M. Azzam, Mohamed A …
    Year: 2019
    Citations: 68

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Professor at IDIVAL, Spain

Professor Javier Crespo is a distinguished physician-scientist and academic leader in the field of digestive and liver diseases. Currently a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL, he has made significant contributions through over 400 original publications, more than 120 clinical trials, and leadership in numerous national and international research projects. With an H-index of 70 and over 30,000 citations, his work has had a profound global impact. He has played a pivotal role in national health strategies, including Spain’s Hepatitis C elimination plan, and served as President of major professional societies such as SEPD. A mentor to numerous doctoral and master’s students, he has also received multiple prestigious awards for his contributions to medicine and research. His leadership at Marqués de Valdecilla University Hospital earned repeated national recognition for excellence in digestive and hepatitis care.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile 

Education

Professor Javier Crespo earned his Degree in Medicine and General Surgery from the University of Cantabria with an Outstanding qualification. He later obtained his Doctorate in Medicine in 1993, receiving the Extraordinary Doctorate Award for academic excellence. His formal education laid a strong foundation for a career marked by clinical rigor and academic depth. In addition to his medical qualifications, he has been accredited as a Professor by ANECA (the Spanish National Agency for Quality Assessment and Accreditation). His academic journey reflects not only excellence in performance but also an enduring commitment to scientific learning and advancement. His scholarly trajectory is rooted in a lifelong dedication to the field of hepatology and digestive pathology, with an early focus on merging basic medical science with clinical research. These formative years have played a crucial role in shaping his influential career in medicine, teaching, and research.

Professional Experience

Professor Crespo has held several prestigious positions throughout his career. He is a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL. He served as Head of the Digestive Service at Marqués de Valdecilla University Hospital from 2010 to 2024. Additionally, he has played strategic roles in healthcare governance, including being a member of Spain’s National Strategic Plan against Hepatitis C since 2015 and coordinator of the AEEH National Liver Health Plan Challenge 2032. His leadership extends to professional societies—he served as President of the Spanish Society of Digestive Pathology (SEPD), President of the National Digestive Commission, and Secretary of the Spanish Association for the Study of the Liver. His professional career reflects a unique blend of clinical excellence, policy leadership, academic mentoring, and research management, making him one of the most respected figures in his specialty.

Research Interest

Professor Crespo’s primary research interests center around digestive and liver diseases, with a particular focus on hepatitis C, liver cirrhosis, and inflammatory bowel diseases. He has led more than 120 clinical trials across Phases I–III and participated in 15 national and 8 international competitive research projects. His translational approach bridges laboratory findings with clinical application, especially in hepatology. Under his leadership, the IDIVAL research group has produced high-impact findings in digestive pathology and liver disease progression. He has authored over 400 original scientific articles, with a strong presence in high-impact journals. His work is cited more than 30,000 times, and he holds an H-index of 70, underscoring his global influence. He is also actively involved in supervising doctoral and postgraduate theses, reflecting his dedication to advancing the next generation of researchers in gastroenterology. His research has contributed significantly to public health, particularly in the management and elimination of hepatitis C.

Award and Honor

Professor Javier Crespo has received numerous national and international awards that recognize both his scientific excellence and public health impact. Among his most prestigious accolades are the Elimination Champions 2023 International Award, granted by the Coalition for Global Hepatitis Elimination, and the International Award at the VI LIFE Forum for HCV Elimination in Lima (2024). Nationally, he has been honored with the Commendation of the Civil Order of Health, the SEPD Gold Medal, and the ACAD Gold Medal. He was also named an Illustrious Torrelaveguense in 2024. Under his leadership, the Digestive Service at Marqués de Valdecilla University Hospital received the Best in Class Award for several consecutive years for excellence in digestive and hepatitis care. His honors reflect not only scientific merit but also his dedication to clinical service and public health leadership, making him one of the most decorated professionals in his field.

Conclusion

In conclusion, Professor Javier Crespo is a highly accomplished and impactful leader in the fields of gastroenterology and hepatology. His career combines outstanding academic achievement, clinical leadership, and translational research excellence. With more than 30,000 citations and an H-index of 70, his scientific contributions have shaped current practices in liver disease treatment and public health strategies. He has held top-level positions in hospitals, universities, research institutes, and national health commissions, evidencing his multifaceted influence. Through his mentorship, he has cultivated a generation of researchers and clinicians, further extending his legacy. His work has not only garnered national and international recognition through prestigious awards but has also led to meaningful improvements in patient care, especially in hepatitis C management. Professor Crespo exemplifies the qualities of a visionary researcher, a compassionate physician, and a dedicated educator—making him exceptionally worthy of recognition such as the Best Researcher Award.

Publications Top Notes

  • Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis

    • Authors: Not listed

    • Year: 2025

    • Citations: 3

  • Letter to the Editor: Optimizing MASLD treatment—A “lead-in phase” before resmetirom

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • Comprehensive Diagnosis of Viral Hepatitis in Spain: Bases for Implementation

    • Authors: Not listed

    • Year: 2025

  • Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    • Authors: ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, …

    • Year: 2023

    • Citations: 4,096

  • Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn’s disease

    • Authors: N Inohara, Y Ogura, A Fontalba, O Gutierrez, F Pons, J Crespo, K Fukase, …

    • Year: 2003

    • Citations: 2,245

  • Modeling NAFLD disease burden in 8 countries (2016–2030)

    • Authors: C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, …

    • Year: 2018

    • Citations: 2,027

  • A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

    • Authors: HSA Newsome, PN Buchholtz, K Cusi, M Linder, T Okanoue, V Ratziu, S Sanyal, …

    • Year: 2021

    • Citations: 1,673

  • Obeticholic acid for the treatment of NASH: Phase 3 trial analysis

    • Authors: ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, …

    • Year: 2019

    • Citations: 1,286

  • Elafibranor resolves NASH without fibrosis worsening

    • Authors: SA Ratziu, V Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, …

    • Year: 2016

    • Citations: 1,217

  • Sofosbuvir and ribavirin in HCV genotypes 2 and 3

    • Authors: ER Zeuzem, S Dusheiko, GM Salupere, R Mangia, A Flisiak, RH Hyland, …

    • Year: 2014

    • Citations: 1,048

  • A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis

    • Authors: Not listed

    • Year: 2024

    • Citations: 983

  • Gene expression of TNF-α and TNF receptors in NASH patients

    • Authors: J Crespo, A Cayón, P Fernández‐Gil, M Hernández‐Guerra, M Mayorga, …

    • Year: 2001

    • Citations: 971

  • Advancing the global public health agenda for NAFLD: Consensus statement

    • Authors: JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, …

    • Year: 2022

    • Citations: 683

Dr. Laura Cerchia | translational cancer research | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Laura Cerchia | translational cancer research | Best Researcher Award

PI, Group Leader at Institute of Endotypes in Oncology, Metabolism and Immunology “G. Salvatore”, National Research Council, Italy

Dr. Laura Cerchia is a leading researcher in cancer-targeting RNA aptamer technologies, serving as Group Leader at the Institute of Endotypes in Oncology, Metabolism and Immunology (CNR, Italy). She pioneered the cell-SELEX method, widely adopted across international labs, and developed multiple aptamers targeting tumor biomarkers such as EGFR, AXL, and PDGFRβ. These aptamers have significant applications in imaging, immunotherapy, and targeted drug delivery, with some now used globally in advanced nanomedicine platforms. Author of over 90 peer-reviewed publications with an H-index of 36, she also holds four international patents. Dr. Cerchia has received numerous grants and serves on several national and international scientific committees, including Horizon Europe’s PHIRE project. Her expertise is recognized through roles as evaluator, editorial board member, and scientific advisor. Her work bridges fundamental research and therapeutic innovation, making her a key figure in translational oncology and a strong candidate for the Best Researcher Award.

Professional Profile 

Scopus Profile
ORCID Profile 

Education

Dr. Laura Cerchia earned her PhD in Biochemical Sciences, building a strong academic foundation in molecular biology and biochemistry. Her educational background equipped her with expertise in RNA biology, molecular diagnostics, and therapeutic development. Her advanced training allowed her to explore the structural and functional aspects of nucleic acids, which later became central to her innovative work in aptamer development. During her academic years, she developed an early interest in translational research, which led her to specialize in the design of synthetic oligonucleotides for medical applications. Her doctoral and postdoctoral studies laid the groundwork for her pioneering approach in using aptamers for targeted cancer therapy. Her education not only deepened her scientific knowledge but also instilled a critical problem-solving mindset that continues to influence her research directions. Her scholarly path reflects a combination of academic rigor and innovative thinking, forming the basis for her future contributions to biomedical science.

Professional Experience

Dr. Laura Cerchia is currently Group Leader at the Institute of Endotypes in Oncology, Metabolism and Immunology “G. Salvatore” (IEOMI) within the National Research Council of Italy (CNR). Her professional journey has been marked by impactful roles in both scientific leadership and collaborative research. She developed the widely used cell-SELEX procedure and generated several clinically relevant RNA aptamers targeting key tumor markers. Beyond laboratory research, Dr. Cerchia serves on editorial boards of journals such as Scientific Reports and Molecules, and holds evaluative and advisory roles in national and international research bodies, including the Horizon Europe-funded PHIRE project. Her career reflects a balance of scientific innovation, project management, and institutional leadership. She has successfully secured multiple research grants, built interdisciplinary teams, and advanced new diagnostic and therapeutic approaches. Her professional experience showcases her ability to lead complex research initiatives and influence the broader scientific and clinical communities.

Research Interest

Dr. Cerchia’s research focuses on the development of nuclease-resistant RNA aptamers for cancer theranostics, therapeutics, and targeted drug delivery. She is especially interested in the use of aptamers as precision tools for recognizing and binding specific biomarkers in tumors, such as EGFR, AXL, and PDGFRβ. Her work involves designing aptamers that can be used for in vitro and in vivo imaging, antagonistic therapies, and as carriers for chemotherapeutics, small molecule inhibitors, siRNAs, or photosensitizers. Her innovations in cell-SELEX have enabled the selection of highly specific aptamers against aggressive cancer types like glioblastoma, NSCLC, and triple-negative breast cancer (TNBC). She is also exploring the potential of aptamers in immunotherapy, including their integration with nanomedicine platforms. Her interest lies in translating basic molecular discoveries into clinical applications, with a strong focus on personalized medicine. Overall, her research aims to bridge gaps between molecular biology, oncology, and therapeutic delivery systems.

Award and Honor

Dr. Laura Cerchia has received multiple national and international recognitions for her contributions to cancer research and aptamer technology. She is the recipient of prestigious research grants and has been invited to serve on scientific evaluation panels, including for the Wellcome Trust (UK), ANR SHAMS, PRIN, and Horizon Europe projects. In 2018, she achieved the National Scientific Qualification, allowing her to function as a Full Professor in general and clinical pathology within Italian universities—an acknowledgment of her academic and professional excellence. She also serves as President and expert evaluator for PRIN 2022 PNRR – ERC Sector LS1, reinforcing her leadership role in shaping national research priorities. Her aptamers are cited and utilized worldwide, further validating the high translational value of her work. In addition to her editorial board positions, these honors demonstrate her broad influence, scientific credibility, and sustained contributions to advancing biomedical research on both national and international levels.

Conclusion

Dr. Laura Cerchia exemplifies the qualities of a world-class biomedical researcher through her pioneering work in RNA aptamer technologies, extensive publication record, and active leadership in the international scientific community. With a robust educational background, decades of impactful professional experience, and deep research expertise, she has made significant contributions to translational cancer therapy. Her innovations have enabled more precise targeting of tumors, enhancing both diagnostic and therapeutic capabilities. Her work has not only influenced academic circles but also spurred technological advances in nanomedicine and drug delivery. The widespread adoption of her aptamers across global research groups attests to the relevance and utility of her discoveries. Coupled with numerous awards, advisory roles, and editorial contributions, her profile reflects excellence, leadership, and a forward-looking vision in biomedical science. Dr. Cerchia’s continued efforts make her a strong candidate for high honors such as the Best Researcher Award and a role model in scientific innovation.

Publications Top Notes

  • Title: A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling
    Authors: Not listed
    Year: 2025

  • Title: A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth
    Authors: Not listed
    Year: 2025

  • Title: Preclinical Toxicological Characterization of Porphyrin-Doped Conjugated Polymer Nanoparticles for Photodynamic Therapy
    Authors: Not listed
    Year: 2025

  • Title: Urine-Stable Aptamer-Conjugated Gold Nanorods for the Early Detection of High-Grade Bladder Cancer Residual Disease
    Authors: Not listed
    Year: 2025
    Citations: 1

  • Title: Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
    Authors: Not listed
    Year: 2024
    Citations: 11

  • Title: Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities
    Authors: Not listed
    Year: Not available
    Citations: 6

  • Title: Subtype Transdifferentiation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression
    Authors: Not listed
    Year: Not available
    Citations: 2

  • Title: Correction to: Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids
    Authors: Not listed
    Year: 2024

  • Title: Correction to: Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles
    Authors: Not listed
    Year: 2022
    Citations: 1

Vipul Wayal | Immunology and Microbiology| Excellence in Research Award

Published on | Editorial Board by World Top Scientists

Dr. Vipul Wayal | Immunology and Microbiology| Excellence in Research Award

Postdoctoral Researcher at Tunghai University, Taiwan

Dr. Vipul Rohidas Wayal is a dynamic postdoctoral researcher specializing in biotechnology, translational medicine, and pharmaceutical sciences. Currently affiliated with Tunghai University in Taiwan, he has demonstrated exceptional expertise in bioactive peptides, metabolic diseases, and immunomodulation. His research has led to several high-impact publications and internationally recognized patents, reflecting strong innovation and translational potential. With a solid academic foundation—holding a Ph.D. in Animal Science and Biotechnology and a Master’s in Pharmaceutics—Dr. Wayal brings interdisciplinary proficiency across advanced bioinformatics, molecular docking, and animal modeling. He has actively contributed to projects targeting MAFLD, T2DM, and atherosclerosis and participated in global scientific forums such as BIO Asia and the Taiwan Innotech Expo. Recognized with scholarships and innovation awards, he is also skilled in scientific writing, grant proposals, and technology transfer. Dr. Wayal’s research impact and forward-thinking approach position him as a promising candidate for honors recognizing excellence in scientific research and innovation.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile 

Education

Dr. Vipul Rohidas Wayal has a robust academic background, reflecting a consistent focus on biomedical research and pharmaceutical sciences. He earned his Ph.D. in Animal Science and Biotechnology from Tunghai University, Taiwan, where his thesis explored the ameliorative effects of bioactive oligopeptides on metabolic-associated fatty liver disease (MAFLD) in murine models. His doctoral work integrated molecular biology, pharmacology, and biotechnology. Prior to this, he completed a Master of Pharmacy (M.Pharm) in Pharmaceutics from Rajiv Gandhi University of Health Sciences, Bangalore, India. His master’s thesis focused on the development of silk protein-based topical sprays for wound healing. Dr. Wayal also holds a Bachelor of Pharmacy from Savitribai Phule Pune University, India, where he conducted research on herbal gel formulations for wound healing. Throughout his education, he has cultivated expertise in drug delivery, biotechnology, and disease modeling, laying a solid foundation for translational research and pharmaceutical innovation.

Professional Experience

Dr. Wayal brings diverse professional experience, combining academic research with industrial roles. He currently serves as a postdoctoral researcher at Tunghai University, Taiwan, where he is involved in projects focusing on novel fermented foods, immunomodulators, and bioactive peptides for metabolic disorders such as NAFLD and T2DM. His earlier academic experience includes extensive work in molecular biology techniques, animal experimentation, and peptide-based therapeutic research. Before transitioning fully into academia, he held several positions in the pharmaceutical industry in India, including Factory Manager at Equine Nutrients and R&D Production Manager at Fibroheal Woundcare Pvt. Ltd., where he was involved in the development and manufacturing of wound-care products. Additionally, he worked as a Manufacturing Officer at Fresenius Kabi, handling large-scale pharmaceutical production. These roles have equipped him with hands-on expertise in technology transfer, quality control, and product development, giving him a practical perspective that complements his research endeavors.

Research Interest

Dr. Vipul Wayal’s research interests lie at the intersection of biotechnology, pharmaceutical sciences, and translational medicine. He is particularly focused on the discovery and functional evaluation of bioactive peptides and proteins for the prevention and treatment of metabolic diseases such as MAFLD, type 2 diabetes, and atherosclerosis. His work integrates molecular docking, bioinformatics, in vivo modeling, and immunological assays to uncover therapeutic pathways and mechanisms, particularly involving Nrf2/HO-1, TLR4/NF-κB, and inflammasome signaling. Additionally, he is involved in the development of functional foods with cardiovascular and immunomodulatory benefits. His broad skill set includes protein purification, ELISA, flow cytometry, and various forms of chromatography and spectroscopy, which support his bench-to-bedside research approach. Dr. Wayal also emphasizes innovative drug delivery systems, especially in peptide-based therapeutics, and is passionate about bridging the gap between laboratory discoveries and clinical applications through patentable, scalable solutions.

Award and Honor

Dr. Vipul Wayal has received recognition for both his academic performance and innovative research contributions. He was awarded the Tunghai University International Student Scholarship consecutively for the academic years 2021–2022 and 2022–2023, acknowledging his academic excellence and research productivity during his doctoral studies. One of his most notable achievements includes receiving the Excellent Idea Certificate for his patented innovation on “Novel Small Molecule Peptides for Anti-MAFLD Activity,” which has been granted in Taiwan and Japan and filed in the United States. His participation in international expos and conferences, such as the Taiwan Innotech Expo and BIO Asia–Taiwan, further emphasizes his growing international profile. These honors reflect his commitment to advancing science through novel and applicable innovations. While his accolades are notable, they also signal his potential for future recognition as his research continues to expand and influence both academic and applied biomedical fields.

Conclusion

In conclusion, Dr. Vipul Rohidas Wayal exemplifies a rising biomedical scientist with an impressive combination of academic excellence, industrial experience, and innovative research. His work in bioactive peptides, metabolic disease therapeutics, and functional food development has resulted in impactful publications and internationally recognized patents. He possesses a wide range of technical skills, from molecular biology to in silico modeling, supported by a solid educational foundation and cross-disciplinary collaborations. With experience spanning academia and pharmaceutical industries, Dr. Wayal effectively bridges fundamental research and real-world applications. His contributions demonstrate both scientific rigor and translational value, making him a strong contender for recognition such as the BExcellence in Research Award. As he continues to lead and contribute to projects addressing global health challenges, his trajectory indicates not only a promising research career but also the capacity to impact public health through innovation and scientific excellence.

Publications Top Notes

  • Title: Novel bioactive peptides alleviate Western diet-induced MAFLD…
    Authors: V. Wayal, S.D. Wang, C.C. Hsieh
    Journal: International Immunopharmacology 148
    Year: 2025
    Citations: 8

  • Title: Bioactive dipeptides mitigate high-fat and high-fructose corn syrup diet-induced MAFLD…
    Authors: V. Wayal, C.C. Hsieh
    Journal: Biomedicine & Pharmacotherapy 168
    Year: 2023
    Citations: 7

  • Title: ASSESSMENT OF WOUND HEALING ACTIVITY OF POTENT HERBAL EXTRACTS GEL IN ALBINO WISTAR RAT
    Authors: V. Wayal, T.N.V.
    Journal: Asian Journal of Pharmaceutical and Clinical Research 15(08)
    Year: 2022
    Citations: 3

  • Title: Design, Development and Evaluation of Silk Based Film Forming Spray for Wound Healing
    Authors: V. Wayal, K. Nagasree, B.A. Vishwanath
    Journal: Journal of Drug Delivery & Therapeutics 11
    Year: 2021
    Citations: 3

  • Title: Chicken meat hydrolysate improves acetaminophen-induced liver injury…
    Authors: V. Wayal, Z.E. Tsai, Y.H. Lin, Y.H. Lai, S.D. Wang, C.C. Hsieh
    Journal: Journal of Agriculture and Food Research 21
    Year: 2025
    Citations: 1

  • Title: Immunomodulatory effects of type II arabinogalactans from Anoectochilus formosanus…
    Authors: Y.L. Huang, W.C. Lin, V. Wayal, C.C. Hsieh
    Journal: Carbohydrate Polymer Technologies and Applications
    Year: 2025

  • Title: Goat Whey Protein Hydrolysate Mitigates High-Fructose Corn Syrup-Induced Hepatic Steatosis…
    Authors: C.H. Shao, V. Wayal, C.C. Hsieh
    Journal: Preprints
    Year: 2025

  • Title: Type II Arabinogalactan from Anoectochilus Formosanus Dampens Allergic Airway Hyperresponsiveness…
    Authors: Y.L. Huang, V. Wayal, W.C. Lin, C.C. Hsieh
    Platform: SSRN Preprint
    Year: 2025